Business Development Team:
Pieter joined the Industry Alliance Office as senior business developer in 2015, thereafter he became the director of business development in 2019. Pieter obtained his PhD in molecular neuroscience in 2011 on campus at the VU University. He broadened his business experience as an entrepreneur as founding partner of an SME developing applications for pharmaceutical companies. In 2015 Pieter decided to focus his career towards collaboration between industry and academia. In this role he is responsible for all business development efforts and specializes in preclinical and clinical drug development and diagnostics for neurodegenerative disorders.
Sasja is appointed as business developer for the Industry Alliance Office in 2018. She obtained her PhD in molecular neurobiology at the VU University and thereafter worked at the German Center for Neurodegenerative Diseases as specialist in automated high-throughput high-content screens. In 2016 Sasja decided to focus her career on building partnerships in the field of neuroscience drug discovery and started as business developer for a preclinical CRO in neuroscience. Currently Sasja specializes in business development for preclinical and clinical drug development in CNS diseases, with a focus on Multiple sclerosis.
Dilek is working as dedicated business developer for the Industry Alliance Office since June 2018.
Dilek has obtained her Pharmacist diploma in Cluj-Napoca (Romania) followed by her Master Diploma in Drug Innovation at the University of Groningen. After completing her PhD at the Netherlands Cancer Institute in 2015, she makes the transition to the field of life sciences consultancy with focus on grant writing and strategic non-dilutive funding advice. In the course of her career, Dilek has developed an interest for innovative discoveries and aims to speed up the valorization and translation of these discoveries to the end-users. To this aim, she focuses on setting up collaborative agreements between the researchers within Amsterdam Neuroscience and the relevant industrial partners. Contact: email@example.com
Prisca is a neuroscientist with a strong interest in innovative and translational neuroscience projects. She has a background in stem cell biology and brain white matter disorders, which she obtained during her PhD at the stem cell laboratory of the pediatric neurology department of Amsterdam UMC. Interested in broadening her horizon towards a strategic business perspective, she joined the IAO in 2018 as a business developer. Here she connects academic neuroscience research with the pharmaceutical and biotechnology industry, to develop and manage research collaborations for high impact translational neuroscience projects.